No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
OMCL240816P40000
- 10.10
- 0.000.00%
15min DelayClose May 17 14:02 ET
0.00High0.00Low
0.00Open10.10Pre Close0 Volume7 Open Interest40.00Strike Price0.00Turnover70.30%IV-1.56%PremiumAug 16, 2024Expiry Date10.56Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9569Delta0.0256Gamma2.78Leverage Ratio-0.0072Theta-0.0099Rho-2.66Eff Leverage0.0067Vega
Intraday
- 5D
- Daily
News
Small and Mid-Cap Stocks Likely to Beat/miss This Earnings Season - BofA
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
Omnicell Price Target Maintained With a $38.00/Share by Benchmark
Omnicell Analyst Ratings
Benchmark Co. Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $38
Benchmark Co. Sticks to Their Buy Rating for Omnicell (OMCL)
Comments
Omnicell stock is undervalued, presenting a buying opportunity. The company's future outlook is optimistic with robust cash flows expected to increase share value. However, consider other factors like financial health before investing.
Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?The company's debt situation and EBIT loss of US$31m over the last twelve months raise concerns about its financial health. The balance sheet is considered far from match-fit and the stock is deemed very risky.
Omnicell's low P/S ratio suggests limited growth. Lackluster future revenue forecasts damages its value. Investors await improved performance as current weak outlook pressures stock price.
Given the falling EPS and poor performance over the last three years, future earnings performance is being considered critical for shareholders. Potential investors are cautioned to ensure they are investing in a high-quality business amid challenges.
The sharp cut to revenue forecasts suggests that investors should temper their expectations for Omnicell, Inc. Also, analysts anticipate slower revenue growth than the wider market, which could lead to increased caution among investors.
Read more